Efficacy of Parent Infant Psychotherapy of mothers with postpartum psychopathological disorders as part of the SKKIPPI study

Conditions

Diagnosis indicating psychiatric care (postpartal mental health disorder mother)

Kaß B, Berghöfer A, Kuchinke L, Ludwig-Koerner C, Schlensog-Schuster F, Roll S, Keil T, Reinhold T.

2025-12-23

10.1186/s12962-025-00696-8

Cost-effectiveness of short-term parent-infant-psychotherapy, results from two randomized controlled trials.

Benjamin Kaß, Anne Berghöfer, Lars Kuchinke, Christiane Ludwig-Koerner, Franziska Schlensog-Schuster et al. (8 authors)

Open Access CRIS of the University of Bern2025-12-23

10.48620/93613

Past attachment experiences, the potential link of mentalization and the transmission of behavior to the child by mothers with mental health problems: cross-sectional analysis of a clinical sample.

Mattheß J, Koch G, Keil T, Roll S, Berghöfer A, Ludwig-Körner C, Schlensog-Schuster F, Sprengeler MK, von Klitzing K, Kuchinke L.

2023-09-052 citations

10.1007/s00787-023-02291-9

Efficacy of Parent-Infant-Psychotherapy with mothers with postpartum mental disorder: study protocol of the randomized controlled trial as part of the SKKIPPI project

Janna Mattheß, Melanie Eckert, Karlheinz Richter, Gabriele Koch, Thomas Reinhold et al. (13 authors)

Trials2020-06-0519 citations

10.1186/s13063-020-04443-7

Interventions

Group 1: Parent Infant Psychotherapy (PIP/ ESKP) in an inpatient or non-inpatient treatment setting (allocation to the treatment setting takes place prior to randomisation depending on the severity of

Eligibility

Sex/Gender

Female

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: diagnosis of at least one psychopathological disorder of the mother during the postpartum phase // Age of the child is 12 months or younger // the mother adequately speaks the German language // written agreement of both custodians

Exclusion criteria

Exclusion criteria: Acute substance abuse of the mother // Acute psychosis of the mother // acute suicidal tendencies of the mother // Alcohol embryopathy suspected // severe chronic organic impairments of the child // other psychotherapy of mother or child // Participation of mother or child in other clinical trials

Design outcomes

Primary

Measure	Time frame
Maternal sensitivity in the interaction with the child measured by the sensitivity subscale of the Emotional Availability Scale (EAS) at the end of the 6-week intervention. The EAS is measured by videotaped interactions of mother and child and evaluated by blinded, certified judges.	—

Secondary

Measure	Time frame
The most important secondary outcome is the child's style of attachment, which is measured after 12 months using the Strange Situation Procedure (SSP) (evaluation of a standard videotaped situation by blinded, certified judges). Further secondary endpoints (mother's symptoms): diagnostic Mini-International Neuropsychiatric Interview (M.I.N.I., after 12 months), Brief Symptom Checklist (BSCL, after 6 weeks), Edinburgh Postnatal Depression Scale (EPDS, after 6 weeks), Anxiety Screening Questionnaire (ASQ-15, after 6 weeks), Scale to Measure Impulsivity and Emotional Dysregulation of Borderline Personality Disorder (IES-27, after 6 weeks), Parental Reflective Functioning Questionnaire (PRFQ-1, after 6 weeks and 12 months), Parental Stress Inventory (PSI, after 6 weeks and 12 months), maternal sensitivity (EAS, after 12 months). Other secondary endpoints (child symptoms and stage of development): Questionnaire of crying, feeding, sleeping (SFS, after 6 weeks), Child Behaviour Checklist (CBCL, after 12 months), development test (ET6-6-R, after 6 weeks and 12 months). Health economic endpoints: Cost analysis after 6 weeks and 12 months.	—

Measure

Time frame

The most important secondary outcome is the child's style of attachment, which is measured after 12 months using the Strange Situation Procedure (SSP) (evaluation of a standard videotaped situation by blinded, certified judges). Further secondary endpoints (mother's symptoms): diagnostic Mini-International Neuropsychiatric Interview (M.I.N.I., after 12 months), Brief Symptom Checklist (BSCL, after 6 weeks), Edinburgh Postnatal Depression Scale (EPDS, after 6 weeks), Anxiety Screening Questionnaire (ASQ-15, after 6 weeks), Scale to Measure Impulsivity and Emotional Dysregulation of Borderline Personality Disorder (IES-27, after 6 weeks), Parental Reflective Functioning Questionnaire (PRFQ-1, after 6 weeks and 12 months), Parental Stress Inventory (PSI, after 6 weeks and 12 months), maternal sensitivity (EAS, after 12 months). Other secondary endpoints (child symptoms and stage of development): Questionnaire of crying, feeding, sleeping (SFS, after 6 weeks), Child Behaviour Checklist (CBCL, after 12 months), development test (ET6-6-R, after 6 weeks and 12 months). Health economic endpoints: Cost analysis after 6 weeks and 12 months.

—

Countries

Germany

Contacts

Public ContactGabriele Koch

International Psychoanalytic University Berlin

skkippi@ipu-berlin.de030300117775

Outcome results

None listed